Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

AIM: To evaluates the effectiveness and safety of the first generation, NS3/4A protease inhibitors (PIs) in clinical practice against chronic C virus, especially in patients with advanced fibrosis. METHODS: Prospective study and non-experimental analysis of a multicentre cohort of 38 Spanish hospita...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Salmerón, Javier, Vinaixa, Carmen, Berenguer, Rubén, Pascasio, Juan Manuel, Sánchez Ruano, Juan José, Serra, Miguel Ángel, Gila, Ana, Diago, Moisés, Romero-Gómez, Manuel, Navarro, José María, Testillano, Milagros, Fernández, Conrado, Espinosa, Dolores, Carmona, Isabel, Pons, José Antonio, Jorquera, Francisco, Rodriguez, Francisco Javier, Pérez, Ramón, Montero, José Luis, Granados, Rafael, Fernández, Miguel, Martín, Ana Belén, Muñoz de Rueda, Paloma, Quiles, Rosa
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2015
Sujets:
Prospective Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533049/
https://ncbi.nlm.nih.gov/pubmed/26290644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i30.9163
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires